Home LiteratureArticle Details
PMID: 7739525 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Inducible degradation of I kappa B alpha in vitro and in vivo requires the acidic C-terminal domain of the protein.

Molecular and cellular biology ·Vol. 15 ·No. 5 ·1995-05-00 ·Pages 2413-9

Rodriguez MS, Michalopoulos I, Arenzana-Seisdedos F, Hay RT

Abstract

After exposure of cells to tumor necrosis factor (TNF), I kappa B alpha is rapidly degraded by a proteolytic activity that is required for nuclear localization and activation of transcription factor NF-kappa B. To investigate this problem, we have developed a cell-free system to study the degradation of I kappa B alpha initiated in vivo. In this in vitro system, characteristics of endogenous I kappa B alpha degradation were comparable to those observed in vivo. Recombinant I kappa B alpha, when added to lysates from cells exposed to TNF, was specifically degraded by a cellular proteolytic activity; however, it was stable in extracts from unstimulated cells. Inhibition characteristics of the proteolytic activity responsible for I kappa B alpha degradation suggest the involvement of a serine protease. Analysis of mutated forms of I kappa B alpha in the in vitro system demonstrated that an I kappa B alpha species which was unable to interact with NF-kappa B was still efficiently degraded. In contrast, deletion of the C-terminal 61 amino acids from I kappa B alpha rendered the protein resistant to proteolytic degradation. Expression of I kappa B alpha mutated forms in COS-7 cells confirmed the importance of the C-terminal domain for the degradation of the protein in vivo following cell activation. Thus, it is likely that the acidic, negatively charged region represented by the C-terminal 61 amino acids of the protein contains residues critical for TNF-inducible degradation of I kappa B alpha.

MeSH Terms
Amino Acid Sequence Animals Cell Line Cell-Free System DNA-Binding Proteins/genetics,metabolism HeLa Cells Humans I-kappa B Proteins Molecular Sequence Data Mutation NF-KappaB Inhibitor alpha NF-kappa B/antagonists & inhibitors,metabolism Recombinant Fusion Proteins/genetics,metabolism Serine Proteinase Inhibitors/metabolism Tumor Necrosis Factor-alpha/pharmacology
Chemicals
DNA-Binding Proteins I-kappa B Proteins NF-kappa B NFKBIA protein, human Recombinant Fusion Proteins Serine Proteinase Inhibitors Tumor Necrosis Factor-alpha NF-KappaB Inhibitor alpha
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Rodriguez M S
Unité d'Immunologie Virale, Institut Pasteur, Paris, France.
Michalopoulos I
Arenzana-Seisdedos F
Hay R T
References (37)
37 references, click to expand
  1. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
    Anal Biochem. 1976 May 7;72:248-54 PMID: 942051
  2. Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors.
    Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):11884-8 PMID: 7991551
  3. I kappa B: a specific inhibitor of the NF-kappa B transcription factor.
    Science. 1988 Oct 28;242(4878):540-6 PMID: 3140380
  4. In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C.
    Mol Cell Biol. 1989 Jun;9(6):2424-30 PMID: 2548081
  5. Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B.
    Nature. 1990 Apr 12;344(6267):678-82 PMID: 2157987
  6. Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity.
    Cell. 1991 Jun 28;65(7):1281-9 PMID: 1829648
  7. Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative.
    Mol Cell Biol. 1992 Feb;12(2):444-54 PMID: 1732726
  8. Construction of solid matrix-antibody-antigen complexes containing simian immunodeficiency virus p27 using tag-specific monoclonal antibody and tag-linked antigen.
    J Gen Virol. 1992 Mar;73 ( Pt 3):653-60 PMID: 1372038
  9. I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family.
    Cell. 1992 Mar 20;68(6):1109-20 PMID: 1339305
  10. Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-kappa B subunit.
    Cell. 1992 Mar 20;68(6):1121-33 PMID: 1547506
  11. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
    Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2489-93 PMID: 1532257
  12. Identification of a naturally occurring transforming variant of the p65 subunit of NF-kappa B.
    Science. 1992 Apr 17;256(5055):367-70 PMID: 1566083
  13. NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats.
    Trends Biochem Sci. 1992 Apr;17(4):135-40 PMID: 1533967
  14. The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50.
    EMBO J. 1992 Aug;11(8):3003-9 PMID: 1639070
  15. Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B.
    Nature. 1992 Aug 13;358(6387):597-9 PMID: 1501714
  16. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62.
    Nucleic Acids Res. 1992 Aug 11;20(15):3821-30 PMID: 1508666
  17. The precursor of NF-kappa B p50 has I kappa B-like functions.
    Cell. 1992 Oct 16;71(2):243-53 PMID: 1423592
  18. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system.
    Int Rev Cytol. 1993;143:1-62 PMID: 8449662
  19. The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers.
    Cell. 1993 Mar 12;72(5):729-39 PMID: 8453667
  20. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway.
    Science. 1993 Mar 26;259(5103):1912-5 PMID: 8096091
  21. p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction.
    Genes Dev. 1993 Apr;7(4):705-18 PMID: 8458581
  22. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha.
    Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2532-6 PMID: 8460169
  23. Role of cysteine62 in DNA recognition by the P50 subunit of NF-kappa B.
    Nucleic Acids Res. 1993 Apr 25;21(8):1727-34 PMID: 8493089
  24. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation.
    Mol Cell Biol. 1993 Jun;13(6):3301-10 PMID: 8497253
  25. The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms.
    Genes Dev. 1993 Jul;7(7A):1266-76 PMID: 8319912
  26. Common structural constituents confer I kappa B activity to NF-kappa B p105 and I kappa B/MAD-3.
    EMBO J. 1993 Jul;12(7):2781-8 PMID: 8334994
  27. Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system.
    Curr Opin Cell Biol. 1993 Jun;5(3):477-87 PMID: 8352966
  28. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B.
    Nature. 1993 Sep 9;365(6442):182-5 PMID: 8371761
  29. Interaction of the C-terminal region of p105 with the nuclear localisation signal of p50 is required for inhibition of NF-kappa B DNA binding activity.
    Nucleic Acids Res. 1993 Sep 25;21(19):4516-23 PMID: 7694229
  30. Proteolytic degradation of MAD3 (I kappa B alpha) and enhanced processing of the NF-kappa B precursor p105 are obligatory steps in the activation of NF-kappa B.
    Nucleic Acids Res. 1993 Nov 11;21(22):5059-66 PMID: 8255759
  31. Promoter analysis of the gene encoding the I kappa B-alpha/MAD3 inhibitor of NF-kappa B: positive regulation by members of the rel/NF-kappa B family.
    EMBO J. 1993 Dec 15;12(13):5043-9 PMID: 8262046
  32. Autoregulation of I kappa B alpha activity.
    Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):28-32 PMID: 8278379
  33. Autoregulation of the NF-kappa B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs.
    Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1346-50 PMID: 8108414
  34. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.
    Cell. 1994 Sep 9;78(5):773-85 PMID: 8087845
  35. Human T-cell leukemia virus type I Tax activation of NF-kappa B/Rel involves phosphorylation and degradation of I kappa B alpha and RelA (p65)-mediated induction of the c-rel gene.
    Mol Cell Biol. 1994 Nov;14(11):7377-84 PMID: 7935451
  36. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B.
    EMBO J. 1994 Nov 15;13(22):5433-41 PMID: 7957109
  37. Multiple nuclear factors interact with the immunoglobulin enhancer sequences.
    Cell. 1986 Aug 29;46(5):705-16 PMID: 3091258
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1995-05-00
Pages
2413-9
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC230470
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]